About this event

  • Date and time Fri 21 Nov 2025 from 8:30am to 5:30pm
  • Location Royal Society of Medicine
  • Organised by Urology

Prostate cancer is the most common cancer among men in the UK, with many diagnosed at an advanced stage. Managing advanced prostate cancer is complex, with evolving treatments improving survival but increasing challenges for patients and clinicians alike.

This focused, multidisciplinary event brings together leading experts to deliver the latest updates on diagnosis, staging, treatment, and complication management. Through expert talks and interactive panels, you’ll gain practical strategies to navigate complexity and improve patient outcomes.

Why Attend?

  • Master cutting-edge diagnostic tools, including advanced imaging and biomarkers.
  • Understand multidisciplinary approaches to metastatic disease and hormone therapy complications.
  • Learn to manage post-treatment complications like radiation cystitis, incontinence, and ureteric obstruction.
  • Engage directly with experts and peers through interactive discussions.

Who Should Attend?

  • Urology consultants and trainees, specialist nurses, oncologists, and oncology trainees.

Register now to secure your place and stay at the forefront of prostate cancer care.

Follow us on: 

Facebook 
Instagram 
LinkedIn 
Twitter 
YouTube 

 

We would like to thank our sponsors Accord, Bayer, Boston Scientific, BXTA, Deciphex, Inify Laboratories, Ipsen, KARL STORZ Endoscopy (UK) Ltd, Kebomed, MSD & AstraZeneca, Prostate Cancer Research, Source BioScience and Teleflex for their support of this event. The companies listed have had no influence or input into the main scientific programme, content or organisation of this meeting.

Show Virtual / In Person rates

Agenda

View the programme

Registration, tea and coffee

Session 1: Making the diagnosis in advanced prostate cancer

Chairs: Mr Ben Lamb and Mr Hide Yamamoto, Consultant Urologist, Maidstone and Tunbridge Wells NHS Trust

Direct to test for all - decision making with limited information and who might not go direct

Dr Alastair Henderson, Consultant Urologist, Maidstone and Tunbridge Wells NHS Trust

MRI in 2025 and AI in imaging

Dr Tristan Barrett, Associate Professor, Department of Radiology, University of Cambridge

The new genetics - can it help in prostate cancer screening? The IMPACT and BARCODE studies

Professor Ros Eeles, Professor of Oncogenetics, The Institute of Cancer Research

Biopsy strategies in the TRANSLATE era

Dr Hide Yamamoto, Consultant Urologist, Maidstone and Tunbridge Wells NHS Trust

Panel discussion

Session 2: Management of metastatic prostate cancer for the urologist

Chairs: Professor Nick James, Professor of Prostate and Bladder Cancer Research, The Institute of Cancer Research, and Dr Alastair Henderson

Managing M1 is you aren't an oncologist: Options in the UK

Professor Nick James

Novel agents: Lutetium/radiopharmaceuticals

Dr Kenrick Ng, Consultant Medical Oncologist, Barts Cancer Centre

Genomics in oncology: BRCA1/2/ATM reports– is this changing who needs a tissue diagnosis?

Dr Diletta Bianchini, Consultant Oncologist Maidstone and Tunbridge Wells NHS Trust

Panel discussion
Tea and coffee break

Session 3: Staging update - conventional and PET imaging in 2025

Chairs: Mr Greg Shaw and Dr Anita Mitra

Role of whole body MRI

Professor Anwar Padhani, Consultant Radiologist and Professor of Cancer Imaging, Mount Vernon Cancer Centre

Debate: PSMA PET/CT should be used to stage newly diagnosed prostate cancer - for the motion

Professor Declan Murphy, Consultant Urologist, Peter MacCallum Cancer Centre

Debate: PSMA PET/CT should be used to stage newly diagnosed prostate cancer - against the motion

Professor Noel Clarke, Consultant Urologist, The Christie NHS Foundation Trust

Discussion and audience vote
Lunch

Session 4: Optimising therapy for higher risk prostate cancer (T3)

Chairs: Mr Ben Lamb and Albert Edwards

Node Dissection in curative treatment in the PSMA Era - Sampling, Templates or Imaging Certainty

Trinity J. Bivalacqua. Professor of Urology and Oncology at the Perelman Center for Advanced Medicine, University of Pennsylvania

Radical prostatectomy, nodal dissection and the role of adjuvant radical treatment

Professor Prasanna Sooriakumaran, Consultant Urologist, University College London Hospital

HDR brachytherapy and external beam radiotherapy

Dr Anita Mitra, Consultant Oncologist, University College London Hospital

Spacers & Radiotherapy: How Can modern Approaches Reduce Toxicity

Dr Albert Edwards, Consultant Clinical Oncologist, University College London

Panel discussion
Tea and coffee break

Session 5: After the cure - radiotherapy and RALP complications and management

Chair: Dr Alastair Henderson

Radiation cystitis and bleeding: New options

Dr Ramesh Thurairaja, Consultant Urologist, Guy's and St Thomas' NHS Foundation Trust

Ureteric obstruction and strictures

Mr Arjun Nathan, NIHR Doctoral Research Fellow, Royal College of Surgeons of England

RALP: Incontinence, slings sphincters and 'man management'

Ms Rachel Barratt, Consultant Urologist, University College London

Andrology: Preventing and managing sexual dysfunction after robotic assisted laparoscopic prostatectomy (RALP) and radiotherapy

Ms Katherine Guest, Senior Clinical Fellow, Andrology, Southampton

Session 6: Questions and answer session - panel discussion: Complications and new developments

Chairs: Mr Ben Lamb and Dr Alastair Henderson

Panel: Selection of 4-5 experts from previous sessions

Panel discussion and audience polls
Closing remarks
Close of meeting
View the programme

Session 1: Making the diagnosis in advanced prostate cancer

Chairs: Mr Ben Lamb and Mr Hide Yamamoto, Consultant Urologist, Maidstone and Tunbridge Wells NHS Trust

Direct to test for all - decision making with limited information and who might not go direct

Dr Alastair Henderson, Consultant Urologist, Maidstone and Tunbridge Wells NHS Trust

MRI in 2025 and AI in imaging

Dr Tristan Barrett, Associate Professor, Department of Radiology, University of Cambridge

The new genetics - can it help in prostate cancer screening? The IMPACT and BARCODE studies

Professor Ros Eeles, Professor of Oncogenetics, The Institute of Cancer Research

Biopsy strategies in the TRANSLATE era

Dr Hide Yamamoto, Consultant Urologist, Maidstone and Tunbridge Wells NHS Trust

Panel discussion

Session 2: Management of metastatic prostate cancer for the urologist

Chairs: Professor Nick James, Professor of Prostate and Bladder Cancer Research, The Institute of Cancer Research, and Dr Alastair Henderson

Managing M1 is you aren't an oncologist: Options in the UK

Professor Nick James

Novel agents: Lutetium/radiopharmaceuticals

Dr Kenrick Ng, Consultant Medical Oncologist, Barts Cancer Centre

Genomics in oncology: BRCA1/2/ATM reports– is this changing who needs a tissue diagnosis?

Dr Diletta Bianchini, Consultant Oncologist Maidstone and Tunbridge Wells NHS Trust

Panel discussion
Comfort break

Session 3: Staging update - conventional and PET imaging in 2025

Chairs: Mr Greg Shaw and Dr Anita Mitra

Role of whole body MRI

Professor Anwar Padhani, Consultant Radiologist and Professor of Cancer Imaging, Mount Vernon Cancer Centre

Debate: PSMA PET/CT should be used to stage newly diagnosed prostate cancer - for the motion

Professor Declan Murphy, Consultant Urologist, Peter MacCallum Cancer Centre

Debate: PSMA PET/CT should be used to stage newly diagnosed prostate cancer - against the motion

Professor Noel Clarke, Consultant Urologist, The Christie NHS Foundation Trust

Discussion and audience vote
Lunch

Session 4: Optimising therapy for higher risk prostate cancer (T3)

Chairs: Mr Ben Lamb and Albert Edwards

Node Dissection in curative treatment in the PSMA Era – Sampling, Templates or Imaging Certainty

Trinity J. Bivalacqua. Professor of Urology and Oncology at the Perelman Center for Advanced Medicine, University of Pennsylvania

Radical prostatectomy, nodal dissection and the role of adjuvant radical treatment

Professor Prasanna Sooriakumaran, Consultant Urologist, University College London Hospital

HDR brachytherapy and external beam radiotherapy

Dr Anita Mitra, Consultant Oncologist, University College London Hospital

Spacers & Radiotherapy: How Can modern Approaches Reduce Toxicity

Dr Albert Edwards, Consultant Clinical Oncologist, University College London

Panel discussion
Comfort break

Session 5: After the cure - radiotherapy and RALP complications and management

Chair: Dr Alastair Henderson

Radiation cystitis and bleeding: New options

Dr Ramesh Thurairaja, Consultant Urologist, Guy's and St Thomas' NHS Foundation Trust

Ureteric obstruction and strictures

Mr Arjun Nathan, NIHR Doctoral Research Fellow, Royal College of Surgeons of England

RALP: Incontinence, slings sphincters and 'man management'

Ms Rachel Barratt, Consultant Urologist, University College London

Andrology: Preventing and managing sexual dysfunction after robotic assisted laparoscopic prostatectomy (RALP) and radiotherapy

Ms Katherine Guest, Senior Clinical Fellow, Andrology, Southampton

Session 6: Questions and answer session - panel discussion: Complications and new developments

Chairs: Mr Ben Lamb and Dr Alastair Henderson

Panel: Selection of 4-5 experts from previous sessions

Panel discussion and audience polls
Closing remarks
Close of meeting

Location

Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom

In-person registration closes at 1:00am on 20 November 2025; virtual registration closes on 21 November 2025. Late registrations will not be accepted. 

The agenda is subject to change at any time 

If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenters and RSM's discretion. 

All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations. 

This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels. 

Checking in Domus Medica 3

While you’re attending this event

If you're an RSM member, why not stay in the comfort of our hotel, Domus Medica, book dinner in the restaurant, or even hire one of our private dining rooms to socialise with your peers?

RSM members enjoy access to our enviable club facilities. For more information, please contact our team at [email protected] or [email protected].

Find out more
Man searching computer

Join the RSM and get free access to digital learning resources

The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online  resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.

Become a member